| 项目编号 |
PRJCA032602 |
| 项目标题 |
Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial |
| 涉及领域 |
Medical |
| 数据类型 |
Transcriptome or Gene expression
|
| 物种名称 |
Homo sapiens
|
| 描述信息 |
Immune checkpoint inhibitors (ICIs) have limited efficacy in microsatellite stable (MSS) metastatic colorectal cancer (mCRC), and combination therapy needs to be further explored. |
| 样品范围 |
Multiisolate |
| 发布日期 |
2024-12-21 |
| 出版信息 |
| PubMed ID |
文章标题 |
杂志名称 |
Doi |
发表年份 |
| 39929851
|
Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial
|
Nature Communications
|
10.1038/s41467-025-56748-3
|
2025
|
|
|
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| Tianjin Science and Technology Commission key project
|
|
21JCZDJC00980
|
|
| Special Research Project of Post-Marketing Clinical Research of Innovative Drugs
|
|
WKZX2024CX102217
|
|
| Tianjin Key Medical Discipline (Specialty) Construction Project
|
|
TJYXZDXK-009A
|
|
|
|
| 提交者 |
Rui
Liu (liurui9003@163.com)
|
| 提交单位 |
Tianjin Medical University Cancer Institute and Hospital |
| 提交日期 |
2024-11-20 |
